Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

X-Ray Crystallographic and Single-Molecule Fluorescence Studies of Beta-2 Glycoprotein I Reveal an Alternative Mechanism of Autoantibody Recognition

William Planer, M.S., Zhiwei Chen, M.S., Mathivanan Chinnaraj, PhD, Xiaobing Zuo, PhD, Vittorio Pengo, MD, Paolo Macor, PhD, Francesco Tedesco, MD, Nicola Pozzi, PhD

Blood (2019) 134 (Supplement_1): 91.

https://doi.org/10.1182/blood-2019-122064

Published: 2019

Journal Articles

Complement activation in antiphospholipid syndrome and its inhibition to prevent rethrombosis after arterial surgery

Pier Luigi Meroni, Paolo Macor, Paolo Durigutto, Luca De Maso, Maria Gerosa, Mariano Ferraresso, Maria Orietta Borghi, Tom Eirik Mollnes, Francesco Tedesco

Blood (2016) 127 (3): 365–367.

https://doi.org/10.1182/blood-2015-09-672139

Published: 2016

Journal Articles

Dynamics of complement activation in aHUS and how to monitor eculizumab therapy

Marina Noris, Miriam Galbusera, Sara Gastoldi, Paolo Macor, Federica Banterla, Elena Bresin, Claudio Tripodo, Serena Bettoni, Roberta Donadelli, Elisabetta Valoti, Francesco Tedesco, Alessandro Amore, Rosanna Coppo, Piero Ruggenenti, Eliana Gotti, Giuseppe Remuzzi

Blood (2014) 124 (11): 1715–1726.

https://doi.org/10.1182/blood-2014-02-558296

Published: 2014

Includes: Supplemental data

Journal Articles

A non–complement-fixing antibody to β2 glycoprotein I as a novel therapy for antiphospholipid syndrome

Chiara Agostinis, Paolo Durigutto, Daniele Sblattero, Maria O. Borghi, Claudia Grossi, Filomena Guida, Roberta Bulla, Paolo Macor, Francesca Pregnolato, Pier Luigi Meroni, Francesco Tedesco

Blood (2014) 123 (22): 3478–3487.

https://doi.org/10.1182/blood-2013-11-537704

Published: 2014

Includes: Supplemental data

Journal Articles

In vivo distribution of β2 glycoprotein I under various pathophysiologic conditions

Chiara Agostinis, Stefania Biffi, Chiara Garrovo, Paolo Durigutto, Andrea Lorenzon, Alpan Bek, Roberta Bulla, Claudia Grossi, Maria O. Borghi, PierLuigi Meroni, Francesco Tedesco

Blood (2011) 118 (15): 4231–4238.

https://doi.org/10.1182/blood-2011-01-333617

Published: 2011

Includes: Supplemental data

Journal Articles

Monocytes/Macrophages Are the Major Targets of the CCL3 Chemokine Produced by CD38 + CD49d + Chronic Lymphocytic Leukemia Cells.

Antonella Zucchetto, Dania Benedetti, Claudio Tripodo, MD, Riccardo Bomben, Fleur Bossi, Michele Dal-Bo, Daniela Marconi, Massimo Degan, Giovanni Del Poeta, Silvia Deaglio, Gianluca Gaidano, MD, Francesco Tedesco, Fabio Malavasi, MD, PhD, Valter Gattei, MD

Blood (2009) 114 (22): 2350.

https://doi.org/10.1182/blood.V114.22.2350.2350

Published: 2009

Journal Articles

C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function

Fleur Bossi, Lucia Rizzi, Roberta Bulla, Alessandra Debeus, Claudio Tripodo, Paola Picotti, Elena Betto, Paolo Macor, Carlo Pucillo, Reinhard Würzner, Francesco Tedesco

Blood (2009) 113 (15): 3640–3648.

https://doi.org/10.1182/blood-2008-03-146472

Published: 2009

Includes: Supplemental data

Journal Articles

CCL3 and CCL4, the Major Chemokines Produced by CD38+ Chronic Lymphocytic Leukemia Cells, Facilitate Microenvironmental Interactions of Neoplastic Cells Via the CD49d/VCAM Pair.

Antonella Zucchetto, Dania Benedetti, Riccardo Bomben, Claudio Tripodo, Fleur Bossi, Michele Dal-Bo, Daniela Marconi, Massimo Degan, Giovanni Del Poeta, Silvia Deaglio, Francesco Tedesco, Gianluca Gaidano, Fabio Malavasi, Valter Gattei

Blood (2008) 112 (11): 1055.

https://doi.org/10.1182/blood.V112.11.1055.1055

Published: 2008

Journal Articles

Recruitment of circulating NK cells through decidual tissues: a possible mechanism controlling NK cell accumulation in the uterus during early pregnancy

Claudia Carlino, Helena Stabile, Stefania Morrone, Roberta Bulla, Alessandra Soriani, Chiara Agostinis, Fleur Bossi, Carlo Mocci, Filippo Sarazani, Francesco Tedesco, Angela Santoni, Angela Gismondi

Blood (2008) 111 (6): 3108–3115.

https://doi.org/10.1182/blood-2007-08-105965

Published: 2008

Includes: Supplemental data

Journal Articles

Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo

Giorgio Zauli, Federica Corallini, Fleur Bossi, Fabio Fischetti, Paolo Durigutto, Claudio Celeghini, Francesco Tedesco, Paola Secchiero

Blood (2007) 110 (2): 536–543.

https://doi.org/10.1182/blood-2007-01-068395

Published: 2007

Journal Articles

Thrombus formation induced by antibodies to β2-glycoprotein I is complement dependent and requires a priming factor

Fabio Fischetti, Paolo Durigutto, Valentina Pellis, Alessandra Debeus, Paolo Macor, Roberta Bulla, Fleur Bossi, Federica Ziller, Daniele Sblattero, Pierluigi Meroni, Francesco Tedesco

Blood (2005) 106 (7): 2340–2346.

https://doi.org/10.1182/blood-2005-03-1319

Published: 2005

Journal Articles

Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo

Aldo Dobrina, Mario Pausa, Fabio Fischetti, Roberta Bulla, Elena Vecile, Elisabetta Ferrero, Alberto Mantovani, Francesco Tedesco

Blood (2002) 99 (1): 185–192.

https://doi.org/10.1182/blood.V99.1.185

Published: 2002

Journal Articles

Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis

Josée Golay, Luisella Zaffaroni, Thomas Vaccari, Manuela Lazzari, Gian-Maria Borleri, Sergio Bernasconi, Francesco Tedesco, Alessandro Rambaldi, Martino Introna

Blood (2000) 95 (12): 3900–3908.

https://doi.org/10.1182/blood.V95.12.3900

Published: 2000

NARROW

X-Ray Crystallographic and Single-Molecule Fluorescence Studies of Beta-2 Glycoprotein I Reveal an Alternative Mechanism of Autoantibody Recognition

Complement activation in antiphospholipid syndrome and its inhibition to prevent rethrombosis after arterial surgery

Dynamics of complement activation in aHUS and how to monitor eculizumab therapy

A non–complement-fixing antibody to β2 glycoprotein I as a novel therapy for antiphospholipid syndrome

In vivo distribution of β2 glycoprotein I under various pathophysiologic conditions

Monocytes/Macrophages Are the Major Targets of the CCL3 Chemokine Produced by CD38 + CD49d + Chronic Lymphocytic Leukemia Cells.

C7 is expressed on endothelial cells as a trap for the assembling terminal complement complex and may exert anti-inflammatory function

CCL3 and CCL4, the Major Chemokines Produced by CD38+ Chronic Lymphocytic Leukemia Cells, Facilitate Microenvironmental Interactions of Neoplastic Cells Via the CD49d/VCAM Pair.

Recruitment of circulating NK cells through decidual tissues: a possible mechanism controlling NK cell accumulation in the uterus during early pregnancy

Osteoprotegerin increases leukocyte adhesion to endothelial cells both in vitro and in vivo

Thrombus formation induced by antibodies to β2-glycoprotein I is complement dependent and requires a priming factor

Cytolytically inactive terminal complement complex causes transendothelial migration of polymorphonuclear leukocytes in vitro and in vivo

Biologic response of B lymphoma cells to anti-CD20 monoclonal antibody rituximab in vitro: CD55 and CD59 regulate complement-mediated cell lysis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only